Related references
Note: Only part of the references are listed.Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
Sanford Kimmel
Therapeutics and Clinical Risk Management (2016)
Immunogenicity and Immune Memory of a Nonadjuvanted Quadrivalent Meningococcal Glycoconjugate Vaccine in Infants
Kirsten P. Perrett et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
A Randomized Trial to Determine the Tolerability and Immunogenicity of a Quadrivalent Meningococcal Glycoconjugate Vaccine in Healthy Adolescents
Lisa A. Jackson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages
Michael Broeker et al.
VACCINE (2009)
Meningococcal B vaccine development and evaluation of efficacy
Loek van Alphen et al.
HUMAN VACCINES (2008)
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants - A randomized controlled trial
Matthew D. Snape et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity
Martin C. J. Maiden et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom
Cressida Auckland et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Long-term protection in children with meningococcal C conjugate vaccination: lessons learned
Ray Borrow et al.
EXPERT REVIEW OF VACCINES (2006)
Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine
Michael Pichichero et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine
KA Poehling et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine
DM Vu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Prospects for vaccine prevention of meningococcal infection
LH Harrison
CLINICAL MICROBIOLOGY REVIEWS (2006)
Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents
H Keyserling et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2005)
Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States
CW Shepard et al.
PEDIATRICS (2005)
Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharicle vaccine in two- to ten-year-old children
M Pichichero et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
CL Trotter et al.
LANCET (2004)
Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants
M Rennels et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
CG Whitney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
ME Ramsay et al.
BRITISH MEDICAL JOURNAL (2003)
Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults
JD Campbell et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United Kingdom
R Borrow et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination
MCJ Maiden et al.
LANCET (2002)
Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States
JR Lingappa et al.
VACCINE (2001)
Medical progress: Meningococcal disease.
NE Rosenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England
ME Ramsay et al.
LANCET (2001)
Share Paper
